Tianyi Liu

Tianyi Liu

Auto-generated profile, based on publicly available information

Tianyi Liu

Division of Neuro-Oncology, Brain Tumor Center, Keck School of Medicine of University of Southern California, Los Angeles, California

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2024 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
TLTianyi Liu
Tianyi Liu
DJDan Jin
Dan Jin
SLSon B. Le
Son B. Le
DCDongjiang Chen
Dongjiang Chen
MSMathew Sebastian
Mathew Sebastian
DTDavid D. Tran
David D. Tran
Immunotherapy has limited efficacy in glioblastoma (GBM) due to the blood–brain barrier and the immunosuppressed or “cold” tumor microenvironment (TME) of GBM, which is dominated by immune-inhibitory cells and depleted of CTL and dendritic cells (DC). Here, we report the development and application of a machine learning precision method to identify cell fate determinants (CFD) that specifically reprogram GBM cells into induced antigen-presenting cells with DC-like functions (iDC-APC). In murine GBM models, iDC-APCs acquired DC-like morphology, regulatory gene expression profile, and functions comparable to natural DCs. Among these acquired functions were phagocytosis, direct presentation of endogenous antigens, and cross-presentation of exogenous antigens. The latter endowed the iDC-APCs with the ability to prime naïve CD8+ CTLs, a hallmark DC function critical for antitumor immunity. Intratumor iDC-APCs reduced tumor growth and improved survival only in immunocompetent animals, which coincided with extensive infiltration of CD4+ T cells and activated CD8+ CTLs in the TME. The reactivated TME synergized with an intratumor soluble PD1 decoy immunotherapy and a DC-based GBM vaccine, resulting in robust killing of highly resistant GBM cells by tumor-specific CD8+ CTLs and significantly extended survival. Lastly, we defined a unique CFD combination specifically for the human GBM to iDC-APC conversion of both glioma stem-like cells and non–stem-like cell GBM cells, confirming the clinical utility of a computationally directed, tumor-specific conversion immunotherapy for GBM and potentially other solid tumors.

16 October 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DCDongjiang Chen
Dongjiang Chen
SLSon B. Le
Son B. Le
HMHarshit Manektalia
Harshit Manektalia
TLTianyi Liu
Tianyi Liu
THTarun E. Hutchinson
Tarun E. Hutchinson
DTDavid D. Tran
David D. Tran
Tumor treating fields (TTFields) use low-intensity, alternating electric fields to exert antitumor activity and have demonstrated efficacy against multiple cancers, including glioblastoma (GBM). Unfortunately, cancer cells inevitably develop resistance to TTFields, highlighting the need to elucidate the underlying mechanisms to develop approaches to induce durable responses. Using a gene network–based machine learning algorithm, we interrogated TTFields-resistant GBM cells and uncovered a regulatory axis anchored by the prostaglandin E2 receptor 3 (EP3) and the transcription factor zinc finger 488 (ZNF488). Mechanistically, TTFields induced EP3 upregulation and nuclear envelope localization, where it formed a complex with ZNF488 to induce resistance to TTFields by promoting self-renewal of glioma stem-like cells (GSC). Overexpression of EP3 and/or ZNF488 in TTFields-sensitive GSC conferred resistance and enhanced self-renewal, whereas expression of noninteracting mutants of these proteins abrogated the formation of the nuclear complex and prevented resistance. Inhibition of either partner in this protein complex in resistant GSC, including those freshly isolated from TTFields-resistant GBM tumors, resensitized cells to the cytotoxic effects of TTFields, concomitant with reduced self-renewal and in vivo tumorigenicity. Importantly, inhibition of EP3 in TTFields-sensitive GSC preemptively halted the development of resistance. The EP3–ZNF488 axis was significantly upregulated in TTFields-resistant GBM tumors, and coexpression of EP3 and ZNF488 in other cancers correlated with lower survival rates. Collectively, these results indicate that the nuclear EP3–ZNF488 axis is necessary and sufficient to establish TTFields resistance, underscoring the potential to target this axis to prevent or reverse resistance in GBM and possibly other cancers. Significance: The EP3–ZNF488 master regulatory axis in cancer stem-like cells drives resistance to treatments like tumor treating fields, opening avenues for developing strategies to enhance therapeutic efficacy.

24 September 2023
Verified
Conference Paper
Open access
MWMingxuan Wang
Mingxuan Wang
TLTianyi Liu
Tianyi Liu
YLYanhua Li
Yanhua Li
Drawing from the framework of endogenous growth theory, technological innovation plays a pivotal role in driving economic expansion. This study, building upon empirical investigations into the impact of technological standardization on economic growth, examines the magnitude of the effect of technological innovation as an intermediary variable in this pathway and formulates corresponding hypotheses. Considering the specific context of China and the evolution of standardization, we conduct research encompassing technological standardization, technological innovation, and economic growth within a unified framework, utilizing China's macroeconomic data spanning from 1989 to 2019 as our dataset. We employ Pearson correlation tests and address multicollinearity issues by applying ridge regression in conjunction with the results of collinearity tests and the mediation model derived from traditional multiple linear regression. This approach yields more stable parameter values. Furthermore, a comparative international analysis was conducted, leading to conclusions and recommendations regarding the achievement of economic growth through the intermediate variable pathway involving the consideration of technological standardization.

17 June 2026
Verified
Other
Open access
DCDongjiang Chen
Dongjiang Chen
SLSon B. Le
Son B. Le
HMHarshit Manektalia
Harshit Manektalia
TLTianyi Liu
Tianyi Liu
THTarun E. Hutchinson
Tarun E. Hutchinson
DTDavid D. Tran
David D. Tran
EP3 inhibition and overexpression reverses and induces TTFields resistance, respectively, in GBM cells. (Supporting Main Figure 2)

17 June 2026
Verified
Other
Open access
PDF file
TLTianyi Liu
Tianyi Liu
DJDan Jin
Dan Jin
SLSon B. Le
Son B. Le
DCDongjiang Chen
Dongjiang Chen
MSMathew Sebastian
Mathew Sebastian
DTDavid D. Tran
David D. Tran
NSCORE (network Systems Calculating Optimal Ranking Engine) (Supporting the Materials and Methods Section)

17 June 2026
Verified
Other
Open access
PDF file
TLTianyi Liu
Tianyi Liu
DJDan Jin
Dan Jin
SLSon B. Le
Son B. Le
DCDongjiang Chen
Dongjiang Chen
MSMathew Sebastian
Mathew Sebastian
DTDavid D. Tran
David D. Tran
KR158-specific splenic T cells were greatly enriched in CD8+ effector T cells following ex vivo expansion and enrichment (Supporting Main Figure 6).